International discussion has been proposed about ethical use of embryoids, human embryo-like organoids in experiments

An article published in Nature, signed by notable personalities in the area of bioethics, discusses the ethical implications of embryoids (organoids) or embryo models, in vitro cell aggregates that model various regions of the embryo to allow their study. These studies are framed...

Our bioethics statement on Trump’s cuts on research with aborted fetal tissues

The President of the United States, Donald Trump, has taken a new step in the fight against abortion, announcing the end of research with tissues from aborted fetuses in federal (NIH, National Institutes of Health) laboratories. While this does not mean that this type of research...

A short review of negative and positive effects of Trump’s restrictions on fetal tissue research

As we published recently (read HERE), the American Administration has placed restrictions on research using fetal tissue, giving rise to a fierce debate among researchers. In this respect, Judd Deere, deputy White House press secretary told Science that enacting the new poli...

Promising new treatment of spinal cord injuries presents bioethical problems should be resolved

Spinal cord injuries are one of the pathologies that present the greatest medical issues in regenrative medicine. Thus, their possible treatment with stem cells has meant—and means—one of the major challenges for regenerative and reparatory medicine. Nevertheless, progress in...

Human fetal tissue debate erupted again. The Trump administration restricts the use of fetal tissues

Moral, and ethical considerations The Trump administration is limiting the use of fetal tissues obtained from elective abortions for biomedical research. Should the government pay for medical research that uses tissue from aborted fetuses? Can human tissue be used as an object of...

In vivo cell reprogramming. A major step forward in regenerative medicine

Cell reprogramming  is revolutionizing the biomedical world, not only because it can obtain cells of different tissues from pluripotent cells, but also because these cells can be genetically modified to be used for the treatment of serious illnesses or to better understand them,...

Nature changes its policy allowing experimentation with human embryos. Why?

Nature Group does not explain the reasons for this change. In any case, the question remains if its decision is based on new scientific evidence. Research using human embryos and embryonic stem cells has prompted a fierce ethical debate. As editors of these types of studies, the...

Human embryos research and the Politics of Bioethics

Ethical objective questions posed by human embryo experimentation are exacerbated by the deregulate gene editing techniques research including biohackers A book has been published by Columbia University, entitled “Experiments in Democracy. Human Embryo Research and the Politics...

Pluripotent stem cells used for regenrative medicine risks. They can develop mutations that favor the production of cancer cells

It should be crucial to check pluripotent cell lines (embryonic and iPS cells) before clinical testing before their use in regenerative medicine The production of pluripotent stem cells, from which virtually all types of cells can be obtained, may be of great use for the...

The future of iPS – induced pluripotent stem cells. New finding increases tremendously their potential for clinical use

Cells now can be obtained from anonymous donors, however, and stored in a cell bank, the costs would be reduced significantly, and their potential for clinical use would increase tremendously A recent article published in Nature discussed some specific aspects regarding the...
12